Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Cerebral Edema l: Introduction

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...

Cerebral Edema ll: Pathophysiology

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term recovery of cauda equina syndrome and sexual dysfunction following delayed decompression of a giant lumbar disc herniation: illustrative case.

Journal of neurosurgery. Case lessons·2026

Same author

Comparative Evaluation of Compressive Strength and Flexural Strength of GC Gold Hybrid, GIC Conventional and Resin-modified Glass-ionomer Cement.

Journal of pharmacy & bioallied sciences·2022

Same author

Why Do People Live or Die? A Retrospective Study from a Crisis Intervention Clinic in North India.

Indian journal of psychological medicine·2022

Same author

Tinnitus and Cognition: Linked?

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2019

Same author

Dexamethasone-induced withdrawal seizure.

Journal of pharmacology & pharmacotherapeutics·2015

Same author

Effect of psychosocial environment in children having mother with schizophrenia.

Psychiatry research·2015

Search research articles

Related Experiment Videos

Facial edema with olanzapine.

Mahima Malhotra¹, Manohar Kant Shrivastava

¹Department of Psychiatry, Dr. Ram Manohar Lohia Hospital, New Delhi-57, India.

General Hospital Psychiatry

|September 3, 2013

Summary

Olanzapine, an antipsychotic, can cause facial edema, a rare but distressing side effect. This condition resolved on its own after discontinuing the medication.

Area of Science:

Pharmacology
Psychiatry
Clinical Medicine

Background:

Olanzapine is a widely used second-generation antipsychotic for various psychiatric conditions.
Adverse drug reactions require careful monitoring in clinical practice.

Purpose of the Study:

To report two cases of facial edema induced by olanzapine.
To highlight a benign yet distressing side effect of olanzapine treatment.

Main Methods:

Case report of two patients experiencing facial edema.
Observation of symptom resolution after olanzapine discontinuation.

Main Results:

Two patients developed facial edema while on olanzapine therapy.
Facial edema resolved spontaneously after cessation of olanzapine.

Keywords:

Edema Olanzapine

Related Experiment Videos

Conclusions:

Olanzapine can induce facial edema, a side effect that may cause significant patient and caregiver distress.
Discontinuation of olanzapine leads to the resolution of this adverse effect.